Analyst Ranking
Top 8%
#366 out of 4868 analysts
Average Return
+8.26%
Win Rate
39%80 out of 203
Risk vs Reward
Poor
Good

Jay Olson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
89bio IncETNB
+578.03%$2.64$17.90
2022-05-12 -
2023-05-12
Buy
89bio IncETNB
+450.31%$3.22$17.72
2022-06-29 -
2023-06-29
Buy
Viking Therapeutics IncVKTX
+439.77%$15.44$83.34
2023-03-27 -
2024-03-27
Buy
Madrigal Pharmaceuticals IncMDGL
+365.01%$64.44$299.65
2022-05-09 -
2023-05-09
Buy
Prothena Corp Public Ltd CoPRTA
+357.12%$12.08$55.22
2020-07-08 -
2021-07-08
Buy

Jay Olson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nektar TherapeuticsNKTR
3Buy$6.00+654.72%Upgrades
2 months ago
Denali Therapeutics IncDNLI
4Buy$42.00+152.25%Maintains
2 months ago
Prothena Corp Public Ltd CoPRTA
10Buy$62.00+573.91%Maintains
3 months ago
Exelixis IncEXEL
6Hold$33.00-15.71%Downgrades
3 months ago
Intellia Therapeutics IncNTLA
9Buy$40.00+350.96%Maintains
4 months ago
Q32 Bio IncQTTB
2Buy$20.00+1,150.00%Maintains
5 months ago
Sagimet Biosciences IncSGMT
1Buy$30.00+769.57%Initiates Coverage On
5 months ago
Terns Pharmaceuticals IncTERN
2Buy$20.00+506.06%Maintains
5 months ago
Inovio Pharmaceuticals IncINO
2Buy$15.00+673.20%Maintains
5 months ago
Biogen IncBIIB
20Buy$255.00+110.60%Maintains
6 months ago
Sage Therapeutics IncSAGE
7Hold$8.00+9.74%Maintains
6 months ago
Incyte CorpINCY
10Buy$82.00+30.86%Maintains
6 months ago
Revolution Medicines IncRVMD
8Buy$60.00+48.59%Maintains
6 months ago
Madrigal Pharmaceuticals IncMDGL
8Buy$350.00+4.82%Maintains
6 months ago
Galecto IncGLTO
4Buy$10.00+257.14%Maintains
6 months ago
Viking Therapeutics IncVKTX
8Buy$138.00+378.00%Reiterates
7 months ago
Marinus Pharmaceuticals IncMRNS
6Buy$6.00+990.91%Upgrades
7 months ago
Gain Therapeutics IncGANX
1Buy$8.00+290.24%Assumes
9 months ago
Bicycle Therapeutics PLCBCYC
3Buy$48.00+460.75%Maintains
9 months ago
Amgen IncAMGN
17Buy$380.00+30.62%Maintains
9 months ago
Neurocrine Biosciences IncNBIX
12Buy$219.00+103.36%Maintains
9 months ago
Editas Medicine IncEDIT
6Hold$12.00+627.27%Maintains
10 months ago
Voyager Therapeutics IncVYGR
5Buy$18.00+405.62%Maintains
a year ago
Sutro Biopharma IncSTRO
5Buy$10.00+852.38%Maintains
a year ago
Crispr Therapeutics AgCRSP
6Buy$95.00+145.67%Maintains
a year ago
Acadia Pharmaceuticals IncACAD
11Hold$19.00+30.14%Maintains
a year ago
Skye Bioscience IncSKYE
1Buy$25.00N/AInitiates Coverage On
a year ago
Ionis Pharmaceuticals IncIONS
3Buy$75.00N/AMaintains
a year ago
Cognition Therapeutics IncCGTX
4Buy$9.00N/AMaintains
a year ago
Jasper Therapeutics IncJSPR
4Buy$80.00N/AMaintains
a year ago
Immuneering CorpIMRX
1Buy$25.00N/AReiterates
a year ago
Biovie IncBIVI
4Buy$50.00N/AMaintains
a year ago
Enanta Pharmaceuticals IncENTA
7Hold$21.00N/AMaintains
a year ago
Immunogen IncIMGN
1Hold$16.00N/AInitiates Coverage On
2 years ago
Mirati Therapeutics IncMRTX
7Buy$62.00N/AMaintains
2 years ago
Cymabay Therapeutics IncCBAY
3Buy$16.00N/AMaintains
2 years ago
89bio IncETNB
4Buy$30.00N/AReiterates
2 years ago
Karuna Therapeutics IncKRTX
4Buy$280.00N/AReiterates
2 years ago
Seagen IncSGEN
8Buy$229.00N/AMaintains
2 years ago
Cincor Pharma IncCINC
3HoldN/AN/ADowngrades
2 years ago
Ayala Pharmaceuticals IncAYLA
4HoldN/AN/ADowngrades
3 years ago
Relmada Therapeutics IncRLMD
2HoldN/AN/ADowngrades
3 years ago
Sierra Oncology IncSRRA
2Hold$55.00N/ADowngrades
3 years ago
Focus Financial Partners IncFOCS
1Buy$71.00N/AMaintains
4 years ago
Korro Bio IncKRRO
2Buy$20.00N/AMaintains
4 years ago
Intercept Pharmaceuticals IncICPT
1Hold$46.00N/ADowngrades
5 years ago
Tempest Therapeutics IncTPST
1Hold$2.00N/ADowngrades
5 years ago
Mediwound LtdMDWD
1Buy$84.00N/AMaintains
7 years ago
Acorda Therapeutics IncACORQ
2Hold$2,520.00N/AMaintains
7 years ago
Medicines CoMDCO
2BuyN/AN/AUpgrades
7 years ago
Neuroderm LtdNDRM
2Buy$42.00N/AUpgrades
8 years ago
Therapeuticsmd IncTXMD
1HoldN/AN/ADowngrades
8 years ago
Portola Pharmaceuticals IncPTLA
1BuyN/AN/AUpgrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.